[HTML][HTML] A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using …

M Gallardo-Gómez, S Moran, M Páez de la Cadena… - Clinical …, 2018 - Springer
Background Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gomez, S Moran, MP de la Cadena… - Clinical …, 2018 - go.gale.com
Background Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

[PDF][PDF] A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gómez, S Moran, MP de la Cadena… - 2018 - researchgate.net
Background: Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gómez, S Moran… - Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

[HTML][HTML] A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using …

M Gallardo-Gómez, S Moran, MP de la Cadena… - Clinical …, 2018 - ncbi.nlm.nih.gov
Background Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gómez, S Moran… - Clinical …, 2018 - europepmc.org
Background: Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo Gómez, S Moran… - … Epigenetics, 2018, vol …, 2018 - diposit.ub.edu
BACKGROUND: Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gómez, S Moran… - Clinical …, 2018 - search.ebscohost.com
Background: Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …

[HTML][HTML] A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using …

M Gallardo-Gómez, S Moran… - Clinical …, 2018 - clinicalepigeneticsjournal …
Colorectal cancer is the fourth cause of cancer-related deaths worldwide, though detection
at early stages associates with good prognosis. Thus, there is a clear demand for novel non …

[PDF][PDF] A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled …

M Gallardo-Gómez, S Moran, MP de la Cadena… - 2018 - scholarlypublications …
Background: Colorectal cancer is the fourth cause of cancer-related deaths worldwide,
though detection at early stages associates with good prognosis. Thus, there is a clear …